Welcome to the e-CCO Library!

P428: Tofacitinib pharmacokinetics and durability of drug exposure in moderate-to-severe Crohn’s disease patients in Phase 2 induction and maintenance studies
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Mukherjee1, C. Deng2, R. Xie2, S.W. Martin3, G. Chan4, M. Moscariello4, W. Niezychowski4, E. Maller*4

Created: Friday, 22 February 2019, 9:49 AM
P429 Clinical utility of thiopurine metabolite monitoring in inflammatory bowel disease and its impact on healthcare utilisation in Singapore
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.Q. Yeo1, H.L. Wee1, H.H. Cheen2, A. WONG2, T.G. Lim2, W.F. Leong3, B. Chowbay3, E. Salazar4, H.H. Shim4, W.P.W. Chan4, S.C. Kong5, W.C. Ong2

Created: Thursday, 30 January 2020, 10:12 AM
P429: Continued postoperative use of biologics for the prevention of recurrence of Crohn’s disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Yu, J.(1);Hyun, H.K.(1);Park, J.(1);Kang, E.A.(1);Park, S.J.(1);Park, J.J.(1);Kim, T.I.(1);Kim, W.H.(1);Cheon, J.H.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P429: Factors associated with weight gain in patients treated with anti-TNF-α for inflammatory bowel disease: a cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Haas1, V. Abitbol2, T. Paupard3, S. Chaussade2, S. Nahon*1

Created: Friday, 22 February 2019, 9:41 AM
P429: Mesalazine has no place in the treatment of Crohn's disease. Really?
Year: 2022
Source: ECCO'22
Authors: MantzarisMD- PhD- AGAF- FEBG- MACG, G.(1);Archavlis, E.(1);Christidou, A.(1);Viazis, N.(1);Georgios, K.(1);
Created: Friday, 11 February 2022, 3:52 PM
P429: Mucosal healing after 3 months of conventional IBD treatment: real life data
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Carlsen A.*1, Tvedt-Gundersen E.1, Isaksen K.1, Leitao K.Ø.1, Karlsen L.N.1, Omdal R.1,2, Aabakken L.3, Grimstad T.1

Created: Wednesday, 20 February 2019, 10:36 AM
P429: Patient skeletal muscle area and postoperative clinical recurrence in Crohn's disease: a retrospective study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Inniss, S.(1,2)*;Simpson, K.(1);Fragkos, K.(1);Wood, C.(1);Smith, A.(2);Rahman, F.(1,2);
Created: Friday, 14 July 2023, 11:05 AM
P429: Robotic-assisted vs. laparoscopic proctectomy for inflammatory bowel disease: Results of the case-match comparison in single institution
Year: 2018
Source: ECCO '18 Vienna
Authors:

M.V. Marino1*, A. Glagoleva2

Created: Thursday, 21 February 2019, 9:14 AM
P429: The effects of psychiatric treatment in patients with inflammatory bowel disease: a prospective study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

O. Yanartas1, H. c. T. Kanı2, E. Bicakci3, Y. Bez1, M. Banzragch3, Z. Senkal1, I. Kilic4, O. Atug3, K. Kuscu1, N. Imeryuz3, H. Akin*3

Created: Friday, 22 February 2019, 9:49 AM
P430 Feasibility and reliability of gastrointestinal ultrasound in pregnant inflammatory bowel disease patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

F. de Voogd1, H. Joshi2, E. Van Wassenaer1, G. D’Haens1, K. Gecse1

Created: Thursday, 30 January 2020, 10:12 AM
P430: Distinct faecal bile acid profiles are associated with sustained remission following exclusive enteral nutrition (EEN) induction therapy in paediatric Crohn's disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Connors1*, R. Bandsma2, B. MacIntyre1, S. Whitehouse1, A. Noble1, M. Rashid1, A. Otley1, J. Van Limbergen1

Created: Thursday, 21 February 2019, 9:14 AM
P430: EirSwitch echoes of NorSwitch: switching biosimilar therapy in an IBD cohort an Irish experience
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Nugent S.*1, Nugent M.2, Mullane D.1, Kelly C.1

Created: Wednesday, 20 February 2019, 10:36 AM
P430: European clinician perspective on withdrawing immunosuppression
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Boyapati1, S. R. Fehily*2, N. S. Ding3

Created: Friday, 22 February 2019, 9:41 AM
P430: Longer-term tofacitinib effectiveness for the treatment of ulcerative colitis: Two-year outcomes from a UK observational cohort study
Year: 2022
Source: ECCO'22
Authors: Honap, S.(1,2);Sharma, E.(1);Ray, S.(1);Mawdsley, J.(1);Anderson, S.(1);Samaan, M.(1);Pavlidis, P.(1,2);Irving, P.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P430: Mesalazine dose modification based on fecal calprotectin levels in ulcerative colitis patients in clinical remission
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Piñero, G.S.(1,2,3)*;Mañosa , M.(1,3);Cañete, F.(1,3);Calafat, M.(1,3);González, L.(1,3);Ruffinengo, O.(2);Domènech, E.(1,3);
Created: Friday, 14 July 2023, 11:05 AM
P430: Prognostic significance of neuropeptide expression in ileal neural plexuses in Crohn’s disease. A retrospective study.
Year: 2021
Source: ECCO'21 Virtual
Authors: Gklavas, A.(1);Tiniakos, D.(2);Karandrea, D.(2);Karamanolis, G.(3);Bamias, G.(4);Papaconstantinou, I.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P430: Prognostic significance of serial faecal calprotectin in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. Zhulina1, Y. Cao2, K. Amcoff3, M. Carlson3, C. Tysk1, J. Halfvarson*1

Created: Friday, 22 February 2019, 9:49 AM
P431 Vitamin D binding protein in the limelight: IBD-related inflammation and circulating levels of vitamin D binding protein, total, free and bioavailable 25-hydroxyvitamin D
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Aksan1,2,3, K. Böttger2,4, N. Hein4, Y. Caicedo-Zea5, I. Diehl6, C. Schumann5, F.P. Armbruster7, J.M. Stein1,2,4

Created: Thursday, 30 January 2020, 10:12 AM
P431: A Pan-European Real-World Study of SB5 biosimilar following transition from reference adalimumab: The PROPER study; 48-week analysis of persistence
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Dignass, A.(1)*;Gisbert, J.P.(2);Bossa, F.(3);Kelly, O.(4);Rahman, M.(5);Lobatón, T.(6);Addison, J.(7);
Created: Friday, 14 July 2023, 11:05 AM
P431: Colonic Treg levels are reduced in patients with ulcerative colitis achieving clinical remission, but are not differentially affected by etrolizumab dose
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Fuh F., Tew W., Keir M., Looney C., Maciuca R., McBride J., Ramirez-Montagut T.

Created: Wednesday, 20 February 2019, 10:36 AM